Oncology Views & Analysis

Views & Analysis

Deep Dive

The promise and pitfalls of molecular testing in oncology

Great strides have been made in the diagnosis and treatment of cancer. However, a variety of challenges remain that frustrate both physicians and patients.

Deep Dive

Smarter thinking about pharmaceutical marketing

Robb DeFilippis, from end-to-end global creative production and sourcing partner Tag, discusses how a more effective multichannel pharma marketing approach can positively affect patient out

Views & Analysis

NICE’s track record in cancer drugs: the impact of the CDF a...

Leela Barham looks back to before the Cancer Drugs Fund and how recommendations have changed through CDF 1.0 and CDF 2.0 to explore it's success.

Views & Analysis

Getting patients round the virtual table

If pharma wants to be truly patient-centric, it needs to be talking to patients.

Deep Dive

Revealing the true value of new cancer drugs to payers

Marc Botteman and Ben van Hout from Pharmerit International discuss how to navigate the value challenges of new cancer treatments like CAR-T with payers.

Views & Analysis

pharmaphorum_podcast-Episode-14-1200x675

AstraZeneca and lung cancer: the pharmaphorum podcast

This episode of the pharmaphorum podcast focuses on lung cancer, with AstraZeneca’s VP, global franchise head, Tagrisso TDR (Tumour Drivers and Resistance) Patrick Connor explaining why the

The promise and pitfalls of molecular testing in oncology

Smarter thinking about pharmaceutical marketing

NICE’s track record in cancer drugs: the impact of the CDF a...

Getting patients round the virtual table

Revealing the true value of new cancer drugs to payers

AstraZeneca and lung cancer: the pharmaphorum podcast

DBV gets peanut allergy therapy programme back on track

How to meet your physicians where they are online

Views & Analysis

Editor's Picks